Dorsey Wright & Associates Invests $1.33 Million in MKS Inc. $MKSI

Dorsey Wright & Associates purchased a new position in MKS Inc. (NASDAQ:MKSI) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,784 shares of the scientific and technical instruments company’s stock, valued at approximately $1,329,000.

Other institutional investors also recently bought and sold shares of the company. USA Financial Formulas bought a new stake in MKS during the 4th quarter valued at about $26,000. Global Retirement Partners LLC lifted its stake in shares of MKS by 560.0% in the fourth quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company’s stock worth $26,000 after buying an additional 140 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of MKS by 616.7% during the fourth quarter. IFP Advisors Inc now owns 172 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 148 shares during the last quarter. Kestra Advisory Services LLC bought a new stake in shares of MKS during the fourth quarter valued at approximately $41,000. Finally, CIBC Private Wealth Group LLC increased its position in shares of MKS by 55.2% during the fourth quarter. CIBC Private Wealth Group LLC now owns 256 shares of the scientific and technical instruments company’s stock valued at $41,000 after acquiring an additional 91 shares in the last quarter. 99.79% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CAO Michelle M. Mccarthy sold 2,434 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $315.23, for a total value of $767,269.82. Following the transaction, the chief accounting officer owned 2 shares in the company, valued at $630.46. This represents a 99.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP David Philip Henry sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $330.50, for a total transaction of $826,250.00. Following the completion of the transaction, the executive vice president directly owned 16,341 shares in the company, valued at approximately $5,400,700.50. The trade was a 13.27% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 53,949 shares of company stock worth $17,446,108. Company insiders own 0.57% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on MKSI shares. Wells Fargo & Company upped their price objective on MKS from $255.00 to $300.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Bank of America lifted their target price on MKS from $380.00 to $500.00 and gave the stock a “buy” rating in a report on Tuesday, June 23rd. Mizuho boosted their price target on MKS from $400.00 to $415.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 8th. JPMorgan Chase & Co. upped their price target on MKS from $305.00 to $365.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Finally, Needham & Company LLC increased their price objective on MKS from $300.00 to $360.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $380.00.

MKS Stock Performance

MKSI stock opened at $324.69 on Friday. The company has a market cap of $21.93 billion, a P/E ratio of 67.93, a price-to-earnings-growth ratio of 0.92 and a beta of 1.93. MKS Inc. has a 1 year low of $88.49 and a 1 year high of $447.62. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.11 and a quick ratio of 0.70. The stock’s fifty day moving average price is $348.85 and its 200-day moving average price is $275.27.

MKS (NASDAQ:MKSI) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.00 by $0.30. MKS had a return on equity of 21.49% and a net margin of 8.06%.The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the business earned $1.71 earnings per share. MKS’s revenue for the quarter was up 15.2% compared to the same quarter last year. MKS has set its Q2 2026 guidance at 2.600-3.200 EPS. On average, equities analysts forecast that MKS Inc. will post 11.77 earnings per share for the current year.

MKS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Wednesday, June 3rd were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, June 3rd. This represents a $1.00 annualized dividend and a dividend yield of 0.3%. MKS’s dividend payout ratio is presently 20.92%.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.